Acuitive Technologies, Inc.
StreetZero Signal 62
About Acuitive Technologies, Inc.
Acuitive Technologies is a medical device manufacturer based in Allendale, NJ, focused on advancing tissue healing. The company develops Citregen®, an FDA-cleared family of devices designed to promote tissue regeneration by increasing cell energy in orthopedic surgery applications. It has raised over $23M across multiple rounds since its founding.
LATEST FUNDINGPrivate Placement
$1.9M
Announced 2026-09-24
TOTAL RAISED$23.11M
IN THE NEWS
- 🔗 Acuitive Technologies - 2025 Company Profile, Funding & Competitors - Tracxn
- 🔗 Acuitive Technologies Stock Price, Funding, Valuation, Revenue & Financial Statements
- 🔗 Invest in Acuitive (Technologies) | StartEngine
- 🔗 Acuitive Technologies - 2026 Funding Rounds & List of Investors - Tracxn
- 🔗 Acuitive Technologies, Inc. - Redefining Tissue Healing
EMPLOYEES11-50
FOUNDED2014
HQAllendale, NJ, US
Industry
Other Health Care
Tags
Medical DevicesOrthopedicsRegenerative Medicine
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Raised $1.875M via private placement in Allendale, NJ
- Total funding exceeds $23M across four rounds including Series A
- Citregen technology is FDA-cleared for orthopedic tissue regeneration
- Trusted by Stryker Corporation with thousands of devices in use
- Maintains 11-50 employees and operates from 50 Commerce Drive, Allendale
Ask StreetZero about Acuitive Technologies, Inc.
Put our AI to work on this deal.
Similar companies
Other Other Health Care deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account